ACHCAcadia Healthcare shows strong fundamental performance with solid profitability and a manageable debt level. Thematic tailwinds in behavioral health are supportive, but recent technical indicators suggest a cautious approach due to a mixed short-term outlook. Recommended for investors seeking long-term exposure to the healthcare sector.
Acadia Healthcare is well-positioned to benefit from increasing demand for behavioral healthcare services, driven by rising awareness of mental health issues and expanding access to care.
Acadia Healthcare demonstrates robust financial health with consistent revenue growth and improving profitability, supported by a stable balance sheet. Diligence in managing debt and a focus on operational efficiency are key strengths.
Acadia Healthcare's stock is trading within a range, showing mixed signals across different timeframes. While some moving averages suggest an upward trend, oscillators indicate a neutral to cautionary stance, suggesting potential consolidation.
| Factor | Score |
|---|---|
| Behavioral Health Demand | 85 |
| Reimbursement Landscape | 70 |
| Market Penetration & Expansion | 75 |
| Competitive Landscape | 65 |
| Factor | Score |
|---|---|
| Valuation | 85 |
| Profitability | 80 |
| Growth | 75 |
| Balance Sheet Health | 80 |
| Cash Flow | 70 |
| Factor | Score |
|---|---|
| Trend Analysis | 70 |
| Momentum | 50 |
| Volume Confirmation | 65 |
| Support & Resistance | 55 |
Improving Earnings
The company has shown positive earnings surprises in the last two reported quarters (2024 Q4 and 2024 Q3), indicating potential for better-than-expected performance.
Reasonable P/E Ratio
The trailing P/E ratio of 18.4 for the TTM period and 14.3 for the fiscal year 2024 are within a reasonable range for the industry, suggesting the stock may not be excessively overvalued based on current earnings.
High Quarterly P/S Ratio
The quarterly P/S ratio for 2025 Q1 is 3.6, and for 2024 Q4 is 4.7, which are relatively high compared to the TTM P/S of 0.8, suggesting potential overvaluation based on recent sales trends.
Negative Revenue Growth in Latest Quarter
While fiscal year 2024 revenue grew, the quarterly revenue for 2025 Q1 ($770.5 million) and 2024 Q4 ($774.2 million) shows a slowdown and potential decline compared to previous quarters.
August 2025
6
Next Earnings Date
H: $0.85
A: $0.71
L: $0.53
H: 860.75M
A: 841.00M
L: 825.00M
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
41.86 USD
The 39 analysts offering 1 year price forecasts for ACHC have a max estimate of 66.00 and a min estimate of 28.00.